Skip to main content

Budget

Our budget supports a broad research portfolio focused on speeding progress across a range of diseases.

Budget Overview

The budget for NCATS is based on the fiscal year (FY) appropriation provided by Congress and the President. The process starts with the President’s Budget request, which is usually released in February. The President's request typically is followed by appropriation hearings by Congress, which result in appropriation bills and reports. The final appropriation bill, if passed by Congress and signed by the President, provides NCATS with its budget for the fiscal year (Oct. 1 through Sept. 30).

As part of the President’s Budget request, we prepare a Congressional Justification to detail our scientific priorities and proposed budget for the upcoming fiscal year.

Information on the overall NIH budget is available from the NIH Office of Budget.

Upcoming Fiscal Year: 2025

Budget Request

On March 11, 2024, the President’s Budget for FY 2025 was released. Specifically, the FY 2025 budget request for NCATS is $926.1 million.

To learn more about NCATS’ FY 2025 budget request and research programs and priorities, view:

Current Fiscal Year: 2024

Continuing Resolution

Per the Extension of Continuing Appropriations and Other Matters Act, 2024, (link) signed into law on March 1, 2024, the National Institutes of Health, including NCATS, is operating under a Continuing Resolution through March 22, 2024. For more information, see CRS Reports Appropriations Status table: 2024.

Budget Request

On March 9, 2023, the President’s Budget for FY 2024 was released. Additional supporting materials were released on March 13, 2023. Specifically, the FY 2024 budget request for NCATS is $923.3 million.

To learn more about NCATS’ FY 2024 budget request and research programs and priorities, view:

Prior Fiscal Year: 2023

Appropriation Law

On Dec. 29, 2022, the President signed into law (P.L. 117-328) the “Consolidated Appropriations Act, 2023.” The Act provides the following for NCATS:

National Center for Advancing Translational Sciences

For carrying out section 301 and title IV of the PHS Act with respect to translational sciences, $923,323,000: Provided, That up to $70,000,000 shall be available to implement section 480 of the PHS Act, relating to the Cures Acceleration Network: Provided further, That at least $629,560,000 is provided to the Clinical and Translational Sciences Awards program.

Previous Budget Requests for NCATS

Authorization

Learn about the authorizing language for NCATS.

Pie chart displaying percentages of NCATS budget: CTSA 69%; All Other 31%. Bar chart displaying NCATS budget summary 2021-2025 in millions: 2021 $852.9; 2022 $882.3; 2023 $923.3; 2024 $923.3; 2025 $926.1.


NCATS Budget Distribution

This graphic is a visual representation of the relative proportions of funding allocated to each of NCATS’ four budget activities: Clinical and Translational Science Activities, Reengineering Translational Sciences, Cures Acceleration Network and Rare Diseases Research.

Source: National Center for Advancing Translational Sciences

Funding History

This chart shows NCATS' funding history and appropriations. 

Source: National Center for Advancing Translational Sciences

Last updated on March 18, 2024